Large-Joint Reconstructive Implants | Market Insights | US | 2021
The COVID-19 pandemic has significantly impacted the US large-joint reconstructive implant market, as hip and knee replacement procedures are delayed and unit sales decline. While the crisis will significantly impact the market in the short-term, other factors will continue to drive market growth. Demand for better patient outcomes will drive the uptake of novel technologies such as patient-conforming and 3-D printed implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques, supporting the expansion of the US large-joint reconstructive implant market. However, downward pricing pressures driven by bundled payment initiatives such as the CJR and BPCI Advanced models, growing outpatient joint replacement volumes, and the increasing influence of GPOs will limit overall revenue potential to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in the US across a 10-year period.
